注射用黄芪多糖治疗原发性肝癌的疗效观察

Clinical efficacy of injection astragalus polysaccharide on treatment primary live cancer patients

目的探讨注射用黄芪多糖对原发性肝癌治疗的临床疗效。方法2007年3月至2008年3月对化疗的96例原发性中晚期肝癌患者,采用随机数字法,随机分为常规化疗药物组(A组)和辅以黄芪多糖注射液药物组(B组),比较两组对原发性肝癌的临床疗效。结果注射用黄芪多糖对原发性肝癌瘤体及AFP值均有明显的改变。结论该药对原发性肝癌有明显的治疗作用,并可提高化疗药物的疗效。

Objective To investigate the clinical efficacy of injection astragalus polysaccharide on treatment primary liver cancer patients. Methods From March 2007 to March 2008,96 primary liver cancer patients with che motherapy randomly divided into conventional chemotherapy group（A） and Astragalus polysaccharide injection group（B）. Clinical efficacy of two groups was compared. Results Injection of Astragalus Polysaccharide primary liver cancer tumor and AFP had a noticeable change in value. Conclusion Astragalus polysaccharide for primary liver cancer have a significant role in the treatment and can improve the efficacy of chemotherapy drugs.